Bristol-Myers Squibb Co./Faktor/Long [4]/BNP

Product class

Factor - Factor Warrant - with Leverage

First exchange day

23/04/2025

Last exchange day

Open End

Performance (1M)

47.64%

Factor type

long

Factor

4.00

Ø Tradable bid size main / secondary

0/0

Ø Tradable ask size main / secondary

0/0

Spread main / secondary

0.00/0.00

Tax presence main / secondary

-/-

Trade further factor warrants for Bristol-Myers Squibb Company without exchange fees.

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE11.48 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 02:47:06 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW11.4811.33
PREV. DAY'S PRICE10.97 (07/21)
CHANGE DAY BEFORE
+0.51
4.65 %
52 WEEK HIGH / LOW15.35 (03/02)4.05 (10/30)

Master Data

WKN
PG2NUR
ISIN
DE000PG2NUR5
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Leverage Product
PRODUCT CLASS
Factor - Factor Warrant - with Leverage
PRODUCT NAME
BRISTOL-MYERS SQUIBB CO. Faktor 4 Long
ISSUER
BNP Paribas Emissions- und Handelsgesellschaft mbH
TRADING SEGMENT
EASY EUWAX
FACTOR TYPE
long
UNDERLYING
BRISTOL-MYERS SQUIBB CO COM USD0.10
UNDERLYING INSTRUMENT
BRISTOL-MYERS SQUIBB CO COM USD0.10
FACTOR
4.00
MULTIPLIER
1.00
EXERCISE TYPE
American
TRADING CURRENCY NOTE
Euro / Units
NOMINAL CURRENCY
EUR
SETTLEMENT CURRENCY
Euro
SMALLEST TRADABLE UNIT
1.00
MINIMUM QUOTATION EUR
3,000.00
MINIMUM QUOTATION UNITS
10,000.00
LAST VALUATION DAY
Open End
PAYMENT DATE
-
FIRST EXCHANGE DAY
23/04/2025
LAST EXCHANGE DAY
Open End
TRADING HOURS
08:00:00 AM - 10:00:00 PM
QUOTATION
fortlaufende Auktion
ISSUE VOLUME
5,000,000
QUANTO
No

Issuer

NAME
BNP Paribas Emissions- und Handelsgesellschaft mbH
ADDRESS
BNP Paribas Zertifikate und Hebelprodukte Senckenberganlage 19 60325 Frankfurt am Main Deutschland
EMAIL ADDRESS
derivate@bnpparibas.com
SERVICE PHONE NUMBER
+49 (0) 69 7193 - 3111
URLhttps://derivate.bnpparibas.com

Product Description

This factor warrant provides the investor with a constant leverage of 4.00 to participate in the positive and negative performance of the Bristol-Myers Squibb Co., which is the underlying instrument. This product has an unlimited term. The issuer has the right to terminate the warrant, subject to a specific notice period.